Market cap
$25 Mln
Revenue (TTM)
$179 Mln
P/E Ratio
--
P/B Ratio
2.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-5.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-7.7
-
Debt to Equity
-11.5
-
Book Value
$--
-
EPS
$-18.5
-
Face value
--
-
Shares outstanding
5,888,716
9 Years Aggregate
CFO
$-191.51 Mln
EBITDA
$-325.17 Mln
Net Profit
$-993.70 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Cardlytics (CDLX)
| -65.0 | 7.5 | -43.7 | -61.0 | -68.9 | -66.2 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Cardlytics (CDLX)
| -69.0 | -59.4 | 59.3 | -91.3 | -53.7 | 127.1 | 480.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Cardlytics (CDLX)
|
4.0 | 25.3 | 179.3 | -100.3 | -51.5 | -- | -- | 2.1 |
| 34.5 | 457.1 | 3,606.2 | -275.7 | -3.6 | -57.7 | -- | 1.1 | |
| 22.8 | 2,547.6 | 5,483.2 | 1,083.3 | 7.7 | 5.6 | 18.6 | 0.8 | |
| 2.3 | 1,216.7 | 1,679.1 | -220.3 | 4.6 | -- | -- | 0.0 | |
| 17.5 | 854.5 | 1,863.5 | 104.4 | 8.2 | 9 | 8.2 | 0.8 | |
| 23.7 | 3,399.2 | 742.0 | 166.9 | 11.1 | 18 | 21.5 | 3.6 | |
| 20.9 | 653.3 | 1,108.2 | -29.4 | 5.2 | -5.7 | -- | 1.3 | |
| 8.7 | 2,133.1 | 3,040.9 | 15.5 | 4.8 | 1.9 | 145.4 | 3.1 | |
| 37.4 | 3,489.5 | 1,300.1 | 313.8 | 11.6 | 11.6 | 18.1 | 1.2 | |
| 5.7 | 105.0 | 425.4 | -50.3 | 0.3 | -- | -- | 28.9 |
Shareholding Pattern
View DetailsAbout Cardlytics (CDLX)
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels,... such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. Cardlytics, Inc. was incorporated in 2008 and is headquartered in Atlanta, Georgia. Read more
-
CEO & Director
Mr. Karim Temsamani
-
Chief Financial Officer
Ms. Alexis DeSieno
-
Headquarters
Atlanta, GA
-
Website
FAQs for Cardlytics (CDLX)
What is the current share price of Cardlytics Inc (CDLX) Today?
The share price of Cardlytics Inc (CDLX) is $4.02 (NASDAQ) as of 28-Aug-2026 16:15 EDT. Cardlytics Inc (CDLX) has given a return of -68.94% in the last 3 years.
What is the current PB & PE ratio of Cardlytics Inc (CDLX)?
Since, TTM earnings of Cardlytics Inc (CDLX) is negative, P/E ratio is not available.
The P/B ratio of Cardlytics Inc (CDLX) is 2.15 times as on 21-Aug-2026, a 78 premium to its peers’ median range of 1.21 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.06 |
-0.94 |
2024 |
-0.10 |
0.27 |
2023 |
-0.27 |
0.27 |
2022 |
-0.04 |
0.09 |
2021 |
-1.72 |
0.32 |
What is the 52 Week High and Low of Cardlytics Inc (CDLX)?
The 52-week high and low of Cardlytics Inc (CDLX) are Rs 61.98 and Rs 3.49 as of 30-Aug-2026.
What is the market cap of Cardlytics Inc (CDLX)?
Cardlytics Inc (CDLX) has a market capitalisation of $ 25 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Cardlytics Inc (CDLX)?
Before investing in Cardlytics Inc (CDLX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.